458 filings
Page 3 of 23
144
se0ky inv
4 Apr 24
Notice of proposed sale of securities
1:40pm
144
zff3d2ptv77i6
4 Apr 24
Notice of proposed sale of securities
1:20pm
S-8
tjz hzc22
3 Apr 24
Registration of securities for employees
4:55pm
8-K
klaf r01rql
25 Mar 24
Entry into a Material Definitive Agreement
4:05pm
424B5
dk5hvv 55
25 Mar 24
Prospectus supplement for primary offering
4:01pm
8-K
0rwx0o26 w7yl
12 Mar 24
BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
7:15am
8-K
o1x926ce samtrov92
14 Feb 24
Regulation FD Disclosure
7:00am
8-K
flfwtghxa sss
12 Feb 24
Entry into a Material Definitive Agreement
12:45pm
SC 13G/A
k56ydk2o9
9 Feb 24
BioXcel Therapeutics / FMR ownership change
8:35am
424B5
mvu1sum 1r
8 Feb 24
Prospectus supplement for primary offering
5:27pm
8-K
qfjs08p
8 Feb 24
Other Events
4:53pm
8-K
75wb2yx fx97wrpk
8 Feb 24
Other Events
7:08am
SC 13G/A
jzn ngkqyxkag2tk2
7 Feb 24
BioXcel Therapeutics / ADAGE CAPITAL PARTNERS GP, L.L.C. ownership change
7:27am
EFFECT
m8cglvow bd8ozxglj
23 Jan 24
Notice of effectiveness
12:15am
CORRESP
8cb7lmb qp8
19 Jan 24
Correspondence with SEC
12:00am
UPLOAD
daggotyld fnm5hf654
19 Jan 24
Letter from SEC
12:00am
4
d7gn99d70bm5pqu5k7vn
18 Dec 23
BioXcel Therapeutics / Frank Yocca ownership change
4:57pm
4
6h9vk
18 Dec 23
BioXcel Therapeutics / Vimal Mehta ownership change
4:55pm